The Role of the Adipokine Resistin in the Pathogenesis and Progression of Epithelial Ovarian Cancer

Overview

Journal Biomedicines

Specialty Biomedical Engineering

Date 2022 Apr 23

PMID 35453670

Authors

Klaudia Parafiniuk

Wiktoria Skiba

Anna Pawlowska

Dorota Suszczyk

Aleksandra Maciejczyk

Iwona Wertel

Affiliations

Soon will be listed here.

Abstract

Obesity is a civilization disease associated with an increased risk of developing cardiovascular diseases, diabetes, and some malignancies. The results concerning the relationship between obesity and epithelial ovarian cancer (EOC) are inconclusive. The higher incidence of neoplasms in obese subjects has led to the development of the adipokine hypothesis. Omental adipocyte cells interact with cancer cells, promoting their migration and metastasis via the secretion of adipokines, growth factors, and hormones. One of the adipokines is resistin. It was shown in vitro that resistin stimulates the growth and differentiation of ovarian cancer cells. Moreover, it increases the level of angiogenesis factors, e.g., matrix metalloproteinase 2 (MMP-2) and vascular epithelial growth factor (VEGF). Additionally, resistin induces epithelial-mesenchymal transition (EMT) and stemness in EOC cell lines. A positive correlation has been shown between a higher level of resistin expression and the stage of histological differentiation of EOC or the occurrence of lymph node metastases. In addition, the overexpression of resistin has been found to act as an independent factor determining disease-free survival as well as overall survival in EOC patients. Growing evidence supports the finding that resistin plays an important role in some mechanisms leading to the progression of EOC, though this issue still requires further research.

Citing Articles

Decoding Resistin Gene Polymorphisms: Implications for Lung Cancer Risk and Clinical Outcomes of Platinum-Based Chemotherapy.

Gong W, Huang D, Zhou T, Zhu X, Huang Y, Lv Y Biomedicines. 2025; 13(2).

PMID: 40002704 PMC: 11852191. DOI: 10.3390/biomedicines13020291.

Omentum provides a special cell microenvironment for ovarian cancer.

Li Z, Fang X, Wang S Cancer Rep (Hoboken). 2023; 6(10):e1858.

PMID: 37605299 PMC: 10598246. DOI: 10.1002/cnr2.1858.

Serum resistin and the risk for hepatocellular carcinoma in diabetic patients.

Abdalla M World J Gastroenterol. 2023; 29(27):4271-4288.

PMID: 37545641 PMC: 10401662. DOI: 10.3748/wjg.v29.i27.4271.

Deciphering Common Traits of Breast and Ovarian Cancer Stem Cells and Possible Therapeutic Approaches.

Lucic I, Kurtovic M, Mlinaric M, Pitesa N, cipak Gasparovic A, Sabol M Int J Mol Sci. 2023; 24(13).

PMID: 37445860 PMC: 10342190. DOI: 10.3390/ijms241310683.

Evaluation of the Potential Diagnostic Utility of the Determination of Selected Immunological and Molecular Parameters in Patients with Ovarian Cancer.

Englisz A, Smycz-Kubanska M, Mielczarek-Palacz A Diagnostics (Basel). 2023; 13(10).

PMID: 37238197 PMC: 10217738. DOI: 10.3390/diagnostics13101714.

References

Thomas D, Apovian C . Macrophage functions in lean and obese adipose tissue. Metabolism. 2017; 72:120-143. PMC: 5516622. DOI: 10.1016/j.metabol.2017.04.005. View

Schwartz D, Lazar M . Human resistin: found in translation from mouse to man. Trends Endocrinol Metab. 2011; 22(7):259-65. PMC: 3130099. DOI: 10.1016/j.tem.2011.03.005. View

Tanha K, Mottaghi A, Nojomi M, Moradi M, Rajabzadeh R, Lotfi S . Investigation on factors associated with ovarian cancer: an umbrella review of systematic review and meta-analyses. J Ovarian Res. 2021; 14(1):153. PMC: 8582179. DOI: 10.1186/s13048-021-00911-z. View

Acquarone E, Monacelli F, Borghi R, Nencioni A, Odetti P . Resistin: A reappraisal. Mech Ageing Dev. 2019; 178:46-63. DOI: 10.1016/j.mad.2019.01.004. View

De Nola R, Menga A, Castegna A, Loizzi V, Ranieri G, Cicinelli E . The Crowded Crosstalk between Cancer Cells and Stromal Microenvironment in Gynecological Malignancies: Biological Pathways and Therapeutic Implication. Int J Mol Sci. 2019; 20(10). PMC: 6567055. DOI: 10.3390/ijms20102401. View

Kujawa K, Lisowska K . [Ovarian cancer--from biology to clinic]. Postepy Hig Med Dosw (Online). 2015; 69:1275-90. DOI: 10.5604/17322693.1184451. View

Polsky S, Ellis S . Obesity, insulin resistance, and type 1 diabetes mellitus. Curr Opin Endocrinol Diabetes Obes. 2015; 22(4):277-82. DOI: 10.1097/MED.0000000000000170. View

Choi H, Pena G, Pradeep S, Cho M, Coleman R, Sood A . Anti-vascular therapies in ovarian cancer: moving beyond anti-VEGF approaches. Cancer Metastasis Rev. 2014; 34(1):19-40. PMC: 4369424. DOI: 10.1007/s10555-014-9538-9. View

Surmi B, Hasty A . Macrophage infiltration into adipose tissue: initiation, propagation and remodeling. Future Lipidol. 2008; 3(5):545-556. PMC: 2575346. DOI: 10.2217/17460875.3.5.545. View

10.

Park H, Kwak M, Kim H, Ahima R . Linking resistin, inflammation, and cardiometabolic diseases. Korean J Intern Med. 2017; 32(2):239-247. PMC: 5339472. DOI: 10.3904/kjim.2016.229. View

11.

Kulbe H, Iorio F, Chakravarty P, Milagre C, Moore R, Thompson R . Integrated transcriptomic and proteomic analysis identifies protein kinase CK2 as a key signaling node in an inflammatory cytokine network in ovarian cancer cells. Oncotarget. 2016; 7(13):15648-61. PMC: 4941267. DOI: 10.18632/oncotarget.7255. View

12.

Borsuk E, Kubiak J . In Vitro Culture of Mouse Oocytes for Meiotic Maturation. Methods Mol Biol. 2018; 1818:13-21. DOI: 10.1007/978-1-4939-8603-3_2. View

13.

Nieman K, Romero I, Van Houten B, Lengyel E . Adipose tissue and adipocytes support tumorigenesis and metastasis. Biochim Biophys Acta. 2013; 1831(10):1533-41. PMC: 3742583. DOI: 10.1016/j.bbalip.2013.02.010. View

14.

Wertel I, Surowka J, Polak G, Barczynski B, Bednarek W, Jakubowicz-Gil J . Macrophage-derived chemokine CCL22 and regulatory T cells in ovarian cancer patients. Tumour Biol. 2015; 36(6):4811-7. PMC: 4529457. DOI: 10.1007/s13277-015-3133-8. View

15.

Olsen C, Green A, Whiteman D, Sadeghi S, Kolahdooz F, Webb P . Obesity and the risk of epithelial ovarian cancer: a systematic review and meta-analysis. Eur J Cancer. 2007; 43(4):690-709. DOI: 10.1016/j.ejca.2006.11.010. View

16.

Santilli F, Liani R, Di Fulvio P, Formoso G, Simeone P, Tripaldi R . Increased circulating resistin is associated with insulin resistance, oxidative stress and platelet activation in type 2 diabetes mellitus. Thromb Haemost. 2016; 116(6):1089-1099. DOI: 10.1160/TH16-06-0471. View

17.

Hsieh Y, Shen C, Huang W, Chin C, Kuo Y, Hsieh M . Resistin-induced stromal cell-derived factor-1 expression through Toll-like receptor 4 and activation of p38 MAPK/ NFκB signaling pathway in gastric cancer cells. J Biomed Sci. 2014; 21:59. PMC: 4089564. DOI: 10.1186/1423-0127-21-59. View

18.

MacLean P, Higgins J, Giles E, Sherk V, Jackman M . The role for adipose tissue in weight regain after weight loss. Obes Rev. 2015; 16 Suppl 1:45-54. PMC: 4371661. DOI: 10.1111/obr.12255. View

19.

Xie Q, Cheng Z, Chen X, Lobe C, Liu J . The role of Notch signalling in ovarian angiogenesis. J Ovarian Res. 2017; 10(1):13. PMC: 5346233. DOI: 10.1186/s13048-017-0308-5. View

20.

Lopez-Janeiro A, Padilla-Ansala C, de Andrea C, Hardisson D, Melero I . Prognostic value of macrophage polarization markers in epithelial neoplasms and melanoma. A systematic review and meta-analysis. Mod Pathol. 2020; 33(8):1458-1465. DOI: 10.1038/s41379-020-0534-z. View